|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
34,000,000 |
Market
Cap: |
N/A |
Last
Volume: |
18,050 |
Avg
Vol: |
18,000 |
52
Week Range: |
$238.6 - $238.6 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Bazemore Robert B |
Chief Operating Officer |
|
2015-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
35,000 |
|
- |
|
Heberlig Chris |
SVP, Finance & Business Ops. |
|
2015-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
24,390 |
|
- |
|
Quinn Anthony |
EVP, CMO, & Head of R&D |
|
2015-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
27,000 |
32,637 |
|
- |
|
Williams Glen |
SVP, Technical Operations |
|
2015-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
25,500 |
25,968 |
|
- |
|
Williams Glen |
SVP, Technical Operations |
|
2015-05-06 |
4 |
AS |
$203.99 |
$342,564 |
D/D |
(1,666) |
468 |
|
- |
|
Williams Glen |
SVP, Technical Operations |
|
2015-05-06 |
4 |
OE |
$40.32 |
$81,534 |
D/D |
1,666 |
2,134 |
|
- |
|
Quinn Anthony |
EVP, CMO & Head of R&D |
|
2015-04-27 |
4 |
AS |
$110.00 |
$1,100,000 |
D/D |
(10,000) |
5,637 |
|
- |
|
Quinn Anthony |
EVP, CMO & Head of R&D |
|
2015-04-27 |
4 |
OE |
$1.70 |
$17,000 |
D/D |
10,000 |
15,637 |
|
- |
|
Quinn Anthony |
EVP, CMO & Head of R&D |
|
2015-04-21 |
4 |
AS |
$108.00 |
$1,080,000 |
D/D |
(10,000) |
5,637 |
|
- |
|
Quinn Anthony |
EVP, CMO & Head of R&D |
|
2015-04-15 |
4 |
AS |
$105.00 |
$1,050,000 |
D/D |
(10,000) |
15,637 |
|
- |
|
Quinn Anthony |
EVP, CMO & Head of R&D |
|
2015-04-15 |
4 |
OE |
$40.74 |
$407,400 |
D/D |
10,000 |
25,637 |
|
- |
|
Williams Glen |
SVP, Technical Operations |
|
2015-04-08 |
4 |
AS |
$96.08 |
$3,830,037 |
D/D |
(39,863) |
468 |
|
- |
|
Williams Glen |
SVP, Technical Operations |
|
2015-04-08 |
4 |
OE |
$40.32 |
$2,031,380 |
D/D |
39,863 |
40,331 |
|
- |
|
Williams Glen |
SVP, Technical Operations |
|
2015-04-07 |
4 |
AS |
$96.04 |
$265,935 |
D/D |
(2,769) |
468 |
|
- |
|
Williams Glen |
SVP, Technical Operations |
|
2015-04-07 |
4 |
OE |
$40.32 |
$111,646 |
D/D |
2,769 |
3,237 |
|
- |
|
Williams Glen |
SVP, Technical Operations |
|
2015-04-07 |
4 |
A |
$76.88 |
$6,535 |
D/D |
85 |
468 |
|
- |
|
Quinn Anthony |
EVP, CMO & Head of R&D |
|
2015-04-06 |
4 |
AS |
$93.76 |
$2,766,201 |
D/D |
(29,503) |
15,637 |
|
- |
|
Quinn Anthony |
EVP, CMO & Head of R&D |
|
2015-04-06 |
4 |
OE |
$0.95 |
$228,069 |
D/D |
19,503 |
45,140 |
|
- |
|
Quinn Anthony |
EVP, CMO & Head of R&D |
|
2015-04-06 |
4 |
A |
$76.88 |
$3,229 |
D/D |
42 |
25,637 |
|
- |
|
Heberlig Chris |
SVP, Finance and Business Ops. |
|
2015-03-11 |
4 |
AS |
$100.44 |
$773,740 |
D/D |
(7,500) |
390 |
|
- |
|
Heberlig Chris |
SVP, Finance and Business Ops. |
|
2015-03-11 |
4 |
OE |
$40.74 |
$305,550 |
D/D |
7,500 |
7,890 |
|
- |
|
Heberlig Chris |
SVP, Finance and Business Ops. |
|
2015-03-11 |
4 |
A |
$76.88 |
$6,612 |
D/D |
86 |
390 |
|
- |
|
Boess Carsten |
SVP, Chief Financial Officer |
|
2015-02-17 |
4 |
AS |
$98.85 |
$4,234,403 |
D/D |
(42,297) |
0 |
|
- |
|
Boess Carsten |
SVP, Chief Financial Officer |
|
2015-02-17 |
4 |
OE |
$1.70 |
$1,206,485 |
D/D |
42,297 |
42,297 |
|
- |
|
Baker Felix |
Director |
|
2015-01-07 |
4 |
B |
$94.19 |
$94,190,000 |
I/I |
1,000,000 |
9,184,771 |
2.25 |
- |
|
372 Records found
|
|
Page 2 of 15 |
|
|